0001209191-23-018012.txt : 20230310
0001209191-23-018012.hdr.sgml : 20230310
20230310195052
ACCESSION NUMBER: 0001209191-23-018012
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20230310
DATE AS OF CHANGE: 20230310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Detheux Michel
CENTRAL INDEX KEY: 0001816196
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 23725337
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
5
1
doc5.xml
FORM 5 SUBMISSION
X0306
5
2022-12-31
0
0
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816196
Detheux Michel
321 ARSENAL STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
36.21
2022-04-15
5
G
0
L
264375
0.00
D
2032-03-11
Common Stock
264375
88125
D
Stock Option (Right to Buy)
36.21
2022-04-15
5
G
0
L
264375
0.00
A
2032-03-11
Common Stock
264375
264375
I
By MG3A
The reporting person transferred these stock options to MG3A, a Belgian partnership of which the reporting person is the manager and the reporting person's spouse is the successor manager.
This stock option vests over four years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer.
/s/ Adi Osovsky, as Attorney-in-Fact
2023-03-10